Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 87
Filtrar
1.
Drug Alcohol Rev ; 42(6): 1559-1565, 2023 09.
Artículo en Inglés | MEDLINE | ID: mdl-37490407

RESUMEN

INTRODUCTION: There is concern around non-prescribed benzodiazepine use, particularly with increasing detections of counterfeit products containing high-risk novel compounds. The aims of this study were to investigate how and which non-prescribed benzodiazepines are being sourced; forms, appearance and packaging; and awareness of risks associated with non-prescribed benzodiazepines. METHODS: Data were collected from a sample of Australians who inject drugs or use ecstasy and/or other illicit stimulants on a monthly or more frequent basis, and who reported past 6-month use of non-prescribed benzodiazepines (n = 235 and n = 250, respectively). Data were collected on source, diversion from a known/trusted prescription, product name and aesthetic characteristics for the last non-prescribed benzodiazepine obtained. RESULTS: Amongst participants who injected drugs, 71% reported that their last non-prescribed benzodiazepines were diverted from a known/trusted prescription, compared to 59% of participants who used ecstasy/other stimulants. Sourcing via cryptomarkets was rare. Across both samples, the majority reported last obtaining substances sold/marketed as diazepam or alprazolam. Participants sourcing via non-diverted means were twice as likely to obtain alprazolam. Known sourcing of novel compounds was rare. Amongst participants who used ecstasy/other stimulants, 36% reported confidence in the content/dose of non-prescribed benzodiazepines even when the source is unknown. DISCUSSION AND CONCLUSIONS: Most participants obtained substances sold as classic/registered benzodiazepines, mostly via diverted prescriptions, with a substantial minority potentially unaware of counterfeits circulating. While diverted use undeniably presents risks, tightening of prescriptions in Australia could inadvertently lead to greater supply of novel benzodiazepines as seen internationally, reinforcing prioritisation of demand and harm reduction strategies.


Asunto(s)
Benzodiazepinas , Sustancias Controladas , Medicamentos Falsificados , Drogas Ilícitas , Mercadotecnía , Daño del Paciente , Conocimiento de la Medicación por el Paciente , Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Adulto Joven , Alprazolam/provisión & distribución , Australia , Benzodiazepinas/economía , Benzodiazepinas/normas , Benzodiazepinas/provisión & distribución , Seguridad Química , Seguridad de Productos para el Consumidor , Sustancias Controladas/economía , Sustancias Controladas/normas , Sustancias Controladas/provisión & distribución , Medicamentos Falsificados/economía , Medicamentos Falsificados/provisión & distribución , Diazepam/provisión & distribución , Abuso de Medicamentos/prevención & control , Abuso de Medicamentos/estadística & datos numéricos , Embalaje de Medicamentos , Medicamentos Genéricos/química , Medicamentos Genéricos/normas , Medicamentos Genéricos/provisión & distribución , Drogas Ilícitas/química , Drogas Ilícitas/normas , Drogas Ilícitas/provisión & distribución , Entrevistas como Asunto , Mercadotecnía/estadística & datos numéricos , N-Metil-3,4-metilenodioxianfetamina , Daño del Paciente/prevención & control , Daño del Paciente/estadística & datos numéricos , Conocimiento de la Medicación por el Paciente/estadística & datos numéricos , Programas de Monitoreo de Medicamentos Recetados , Riesgo , Autoinforme , Incertidumbre
2.
Antimicrob Resist Infect Control ; 11(1): 24, 2022 02 03.
Artículo en Inglés | MEDLINE | ID: mdl-35115030

RESUMEN

BACKGROUND: Numerous studies evaluated the association of education level with misuse of antibiotics by the general population, yet divergent findings were reported. Therefore, a meta-analysis was conducted to summarize this association. METHODS: A categorical and continuous dose-response meta-analysis of the association of education level with antibiotic misuse was undertaken. Summary odds ratios (ORs) and their 95% confidence intervals (CIs) were estimated using random-effect model. RESULTS: The meta-analysis included 85 studies from 42 countries of different socioeconomic status. Compared to low education (≤ 9 years), medium education (> 9-12 years) is associated with 20% lower odds of antibiotic misuse in high-income countries (OR = 0.80; 95% CI 0.66, 0.97), while high education (> 12 years) is associated with 14% lower odds of any aspect of antibiotic misuse (OR = 0.86; 95% CI 0.72, 1.03). The association is more pronounced in Middle East (OR = 0.64; 95% CI 0.42, 1.00) and countries of lower-middle economies (OR = 0.67, 95% CI 0.41, 1.11). Inversely, in Europe, high education is associated with 25% higher odds of antibiotic misuse (OR = 1.25, 95% CI 1.00, 1.58). Each additional year of education was associated with 4% lower odds of any aspect of antibiotic misuse in lower-middle economies (OR = 0.96; 95% CI 0.92, 1.00) and in Middle East (OR = 0.96; 95% CI 0.93, 1.00). Conversely, it was associated with 3% higher odds of antibiotic storage, a specific type of misuse (OR = 1.03, 95% CI 1.01, 1.06). CONCLUSION: Individuals misuse antibiotics irrespective of their education level. Intervention programs to enhance the proper use of antibiotics should target all communities independent of their education level.


Asunto(s)
Antibacterianos/uso terapéutico , Relación Dosis-Respuesta a Droga , Abuso de Medicamentos/estadística & datos numéricos , Escolaridad , Humanos
4.
Yakugaku Zasshi ; 141(12): 1389-1392, 2021.
Artículo en Japonés | MEDLINE | ID: mdl-34853209

RESUMEN

We discuss the current status of, and possible countermeasures for, acute drug poisoning among adolescents using OTC drugs. In the last 10 years, 36 patients aged <20 years who overdosed on OTC drugs were examined for the type of drug ingested, its active ingredients in cases of lethal dose intake, and the relevant place of purchase. Patients aged <20 years accounted for 30% of all the cases. The ingestion of multi-ingredient common-cold medication was the highest at 23%, and no ingestion of any first-class OTC drugs was observed. Caffeine accounted for 54% of the cases of lethal dose intake. At 80%, the most common method of drug purchase was from drugstores and other OTC vendors. In recent years, the number of adolescents patients who take lethal doses of OTC drugs has been increasing, and new measures are needed to avoid such cases. School pharmacists and vendors play a major role in reducing the incidences of drug poisoning. As drugs can be easily purchased over the counter, increasing the vendors' awareness of the problem throughout society may be the quickest way to reduce the incidences of acute drug poisoning among adolescents.


Asunto(s)
Conducta del Adolescente , Comportamiento del Consumidor , Abuso de Medicamentos/prevención & control , Abuso de Medicamentos/estadística & datos numéricos , Medicamentos Compuestos contra Resfriado, Gripe y Alergia/envenenamiento , Medicamentos sin Prescripción/envenenamiento , Enfermedad Aguda , Adolescente , Factores de Edad , Cafeína/envenenamiento , Comercio , Femenino , Humanos , Incidencia , Masculino , Medicamentos Compuestos contra Resfriado, Gripe y Alergia/efectos adversos , Medicamentos sin Prescripción/efectos adversos , Farmacias , Factores de Tiempo
5.
Neuropharmacology ; 198: 108766, 2021 10 15.
Artículo en Inglés | MEDLINE | ID: mdl-34454912

RESUMEN

The coronavirus disease 2019 (Covid-19) pandemic intensified the already catastrophic drug overdose and substance use disorder (SUD) epidemic, signaling a syndemic as social isolation, economic and mental health distress, and disrupted treatment services disproportionally impacted this vulnerable population. Along with these social and societal factors, biological factors triggered by intense stress intertwined with incumbent overactivity of the immune system and the resulting inflammatory outcomes may impact the functional status of the central nervous system (CNS). We review the literature concerning SARS-CoV2 infiltration and infection in the CNS and the prospects of synergy between stress, inflammation, and kynurenine pathway function during illness and recovery from Covid-19. Taken together, inflammation and neuroimmune signaling, a consequence of Covid-19 infection, may dysregulate critical pathways and underlie maladaptive changes in the CNS, to exacerbate the development of neuropsychiatric symptoms and in the vulnerability to develop SUD. This article is part of the special Issue on 'Vulnerabilities to Substance Abuse'.


Asunto(s)
COVID-19/epidemiología , Abuso de Medicamentos/estadística & datos numéricos , SARS-CoV-2 , Trastornos Relacionados con Sustancias/epidemiología , Adaptación Psicológica , Enzima Convertidora de Angiotensina 2/fisiología , Animales , Axones/virología , COVID-19/inmunología , COVID-19/fisiopatología , COVID-19/psicología , Comorbilidad , Susceptibilidad a Enfermedades , Células Endoteliales/virología , Humanos , Inmunidad Innata , Inflamación/etiología , Quinurenina/metabolismo , Neuronas/virología , Neurotransmisores/metabolismo , Mucosa Olfatoria/virología , Pandemias , SARS-CoV-2/fisiología , Aislamiento Social , Estrés Psicológico , Trastornos Relacionados con Sustancias/etiología , Trastornos Relacionados con Sustancias/fisiopatología , Triptófano/metabolismo , Tropismo Viral
6.
Antimicrob Resist Infect Control ; 10(1): 129, 2021 08 30.
Artículo en Inglés | MEDLINE | ID: mdl-34461998

RESUMEN

BACKGROUND: Non-prescription antibiotic use at community is a main driver of antimicrobial resistance. Cough is a common condition and prevalent in all townships, including China. This study aims to investigate the non-prescription antibiotic use for cough in China and explore to which extent antibiotic use knowledge was correctly instructed in communities. METHODS: A probability-proportionate-to-size sampling method was adopted to survey from all 14 townships in Yiwu city, China. All participants were investigated by face-to-face interview on Portable Android Devices. The continuous variables were presented by mean and standard deviation or medium and inter-quartile range (IQR). The categorical variables were presented using percentage or constituent ratio. Chi-square test for univariate analysis and logistic regression for multivariate analysis were conducted to assess the odds ratios and 95% confidence intervals, respectively. RESULTS: A total of 3034 respondents across all the 14 townships and the 50 natural villages/streets completed all key items of the questionnaire. Of 2400 (79.10%) respondents stated that they experienced cough in the past 12 months with the medium age of 36.5 (IQR: 26-49) and 12.21% (293/2400) respondents had the non-prescription antibiotic use behavior. Among those 293 respondents, the proportion of non-prescription antibiotic use for cough peaked at around 16% among people aged 30-39 years old. The major sources of antibiotics were pharmacy (77.70%) and/or family storage (43.92%). CONCLUSIONS: Non-prescription antibiotics use for cough is prevalent in the community, especially among people in their thirties. Strengthened drug purchase regulation and well-trained professional pharmacists would be promising alternatives to ameliorate AMR. Moreover, penetrating antibiotics knowledge to common citizens and is an urgent task to alleviate antimicrobial resistance. Therefore, proactive policies and regulations should be made to improve current situations.


Asunto(s)
Antibacterianos/uso terapéutico , Tos/tratamiento farmacológico , Abuso de Medicamentos , Adolescente , Adulto , Anciano , China , Abuso de Medicamentos/estadística & datos numéricos , Femenino , Humanos , Modelos Logísticos , Masculino , Persona de Mediana Edad , Medicamentos sin Prescripción , Oportunidad Relativa , Prescripciones , Encuestas y Cuestionarios , Adulto Joven
8.
Lancet Glob Health ; 9(5): e610-e619, 2021 05.
Artículo en Inglés | MEDLINE | ID: mdl-33713630

RESUMEN

BACKGROUND: Antimicrobial misuse is common in low-income and middle-income countries (LMICs), and this practice is a driver of antibiotic resistance. We compared community-based antibiotic access and use practices across communities in LMICs to identify contextually specific targets for interventions to improve antibiotic use practices. METHODS: We did quantitative and qualitative assessments of antibiotic access and use in six LMICs across Africa (Mozambique, Ghana, and South Africa) and Asia (Bangladesh, Vietnam, and Thailand) over a 2·5-year study period (July 1, 2016-Dec 31, 2018). We did quantitative assessments of community antibiotic access and use through supplier mapping, customer exit interviews, and household surveys. These quantitative assessments were triangulated with qualitative drug supplier and consumer interviews and discussions. FINDINGS: Vietnam and Bangladesh had the largest proportions of non-licensed antibiotic dispensing points. For mild illness, drug stores were the most common point of contact when seeking antibiotics in most countries, except South Africa and Mozambique, where public facilities were most common. Self-medication with antibiotics was found to be widespread in Vietnam (55·2% of antibiotics dispensed without prescription), Bangladesh (45·7%), and Ghana (36·1%), but less so in Mozambique (8·0%), South Africa (1·2%), and Thailand (3·9%). Self-medication was considered to be less time consuming, cheaper, and overall, more convenient than accessing them through health-care facilities. Factors determining where treatment was sought often involved relevant policies, trust in the supplier and the drug, disease severity, and whether the antibiotic was intended for a child. Confusion regarding how to identify oral antibiotics was revealed in both Africa and Asia. INTERPRETATION: Contextual complexities and differences between countries with different incomes, policy frameworks, and cultural norms were revealed. These contextual differences render a single strategy inadequate and instead necessitate context-tailored, integrated intervention packages to improve antibiotic use in LMICs as part of global efforts to combat antibiotic resistance. FUNDING: Wellcome Trust and Volkswagen Foundation.


Asunto(s)
Antibacterianos/administración & dosificación , Abuso de Medicamentos/estadística & datos numéricos , Conocimientos, Actitudes y Práctica en Salud , Accesibilidad a los Servicios de Salud/estadística & datos numéricos , África , Asia , Bangladesh , Países en Desarrollo , Estudios de Evaluación como Asunto , Femenino , Ghana , Humanos , Masculino , Mozambique , Pobreza , Investigación Cualitativa , Características de la Residencia , Sudáfrica , Encuestas y Cuestionarios , Tailandia , Vietnam
10.
Expert Rev Anti Infect Ther ; 19(6): 797-804, 2021 06.
Artículo en Inglés | MEDLINE | ID: mdl-33251896

RESUMEN

Objectives: Misuse of antibiotics, especially in low-and-middle-income countries is a major contributor to antimicrobial resistance. Medical students are antibiotic consumers and prescribers in the future. This study aimed to assess antibiotic knowledge and utilization among medical students in the Republic of Mali, and to determine the relationship between knowledge and health-seeking behavior in relation to antibiotic use.Methods: A cross-sectional survey was conducted in the only public medical university in Mali. The questionnaire explored knowledge about antibiotics of medical students, and health behaviors for self-limiting illness. Data were analyzed in SPSS.Results: A total of 446 medical students completed the questionnaire. The average knowledge score was 4.12 out of 10. Students with clinical experience performed higher (4.79 vs 3.74, p< 0.01); 391(87.7%) medical students reported experience of self-limiting diseases in the past year. Of these 197(50.4%) went to see a doctor, 160 (81.2%) of whom were prescribed antibiotics: 151 medical students self-treated, with 121(80.1%) using antibiotics.Conclusions: This study shows poor knowledge and massive misuse of antibiotics among medical students in Mali. Promoting education on the mechanism of antibiotics, antimicrobial resistance and rational antibiotic use among medical students should be a priority in the medical school curriculum.


Asunto(s)
Antibacterianos/administración & dosificación , Abuso de Medicamentos/estadística & datos numéricos , Conocimientos, Actitudes y Práctica en Salud , Estudiantes de Medicina/estadística & datos numéricos , Adolescente , Estudios Transversales , Femenino , Humanos , Masculino , Malí , Aceptación de la Atención de Salud/estadística & datos numéricos , Encuestas y Cuestionarios , Adulto Joven
11.
Body Image ; 36: 53-63, 2021 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-33232935

RESUMEN

Prior research has established that sexual minority (SM) individuals are more likely to experience disordered body image behaviors and concerns than heterosexual individuals. This increased risk may be explained by minority stress theory - that SM individuals are subject to SM-specific stressors, leading to health disparities - but this has not yet been fully examined. Furthermore, this theory states that SM community involvement may mitigate negative outcomes. The current study examines whether minority stress is associated with screening positive for an eating disorder, screening positive for body dysmorphic disorder, and appearance- and performance-enhancing drug misuse in a sample of SM individuals (483 women and 479 men) in the US. This study also examines whether the effect of minority stress is moderated by SM community involvement. Logistic regressions were conducted for each type of minority stress (internalized homophobia, sexual orientation concealment, and heterosexist discrimination) interacting with community involvement. After correction for multiple comparisons, all minority stressors and community involvement were positively associated with increased odds of disordered body image behaviors and concerns, with no evidence of a buffering effect for community involvement. The lack of a buffering effect is contrary to minority stress theory and may inform future prevention efforts.


Asunto(s)
Trastorno Dismórfico Corporal/psicología , Participación de la Comunidad/estadística & datos numéricos , Abuso de Medicamentos/estadística & datos numéricos , Trastornos de Alimentación y de la Ingestión de Alimentos/epidemiología , Sustancias para Mejorar el Rendimiento/uso terapéutico , Minorías Sexuales y de Género/psicología , Estrés Psicológico/epidemiología , Adolescente , Adulto , Trastorno Dismórfico Corporal/epidemiología , Femenino , Humanos , Masculino , Minorías Sexuales y de Género/estadística & datos numéricos , Encuestas y Cuestionarios , Estados Unidos/epidemiología , Adulto Joven
12.
Braz. J. Pharm. Sci. (Online) ; 57: e18064, 2021. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1339301

RESUMEN

Medication discrepancies are of great concern in hospitals because they pose risks to patients and increase health care costs. The aim of this study was to estimate the prevalence of inconsistent medication prescriptions to adult patients admitted to a hospital in southern Santa Catarina, Brazil. This was a patient safety study on patients recruited between November 2015 and June 2016. The participants were interviewed and had their medical records reviewed. Discrepant medications were considered those that did not match between the list of medicines taken at home and the prescribed drugs for treatment in a hospital setting. Of the 394 patients included, 98.5% took continuous-use medications at home, with an average of 5.5 medications per patient. Discrepancies totaled 80.2%, The independent variables associated with the discrepancies were systemic arterial hypertension, hypercholesterolemia, vascular disease, number of medications taken at home, and poor documentation of the medications in the medical record. Findings from this study allowed us to conclude there was a high rate of prescription medication misuse. Medication reconciliation is crucial in reducing these errors. Pharmacists can help reduce these medication-related errors and the associated risks and complications.


Asunto(s)
Humanos , Masculino , Femenino , Adolescente , Adulto , Persona de Mediana Edad , Anciano , Anciano de 80 o más Años , Farmacéuticos/ética , Prescripciones de Medicamentos/normas , Costos de la Atención en Salud , Conciliación de Medicamentos/ética , Errores de Medicación/efectos adversos , Pacientes/clasificación , Preparaciones Farmacéuticas , Registros Médicos/estadística & datos numéricos , Seguridad del Paciente , Abuso de Medicamentos/estadística & datos numéricos , Hospitales/provisión & distribución
13.
PLoS One ; 15(12): e0244373, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33347511

RESUMEN

BACKGROUND: The use of oral contraceptive pills (OCPs) as a birth control method is very common worldwide. OCPs have many other labeled non-contraceptive indications, and as a result there is an associated risk of improper use, as with any other medications. This study was designed to assess the unforeseen improper uses of OCPs observed by community pharmacists in Jordan. METHOD: A cross-sectional study design was conducted using a self-administered survey. A convenience sample (n = 380) of Jordanian community pharmacists, were recruited through social media resources. The survey included multiple-choice and open-ended questions. Descriptive statistics and correlation analyses were completed using SPSS. RESULTS: More than half of the recruited pharmacists (55.3%) were female, and the mean age of the participants was 32.58 ± 9.94. The majority of the pharmacists (85%) had good knowledge about the non-contraceptive indications of OCPs. About 53% of them confirmed their exposure to cases of the improper use of OCPs. About 67.5% of the pharmacists who confirmed exposure to such cases, reported the topical use of OCPs for the enhancement of hair growth. Around 15% of those pharmacists stated that OCPs were used to give negative results for addictive drug screening tests. In the event that the pharmacists suspected improper use, more than 90% suggested they would refrain from dispensing the pills. CONCLUSION: This study has spotlighted many unforeseen uses of OCPs in Jordan and highlighted the need for restricted national regulations on the monitoring of OCP prescription/selling patterns in Jordan by policymakers. Moreover, there is a need for the establishment of national educational programs for the Jordanian community regarding the safe proper use of OCPs.


Asunto(s)
Anticonceptivos Orales/administración & dosificación , Abuso de Medicamentos/estadística & datos numéricos , Farmacéuticos/estadística & datos numéricos , Administración Tópica , Adulto , Anticonceptivos Orales Combinados , Estudios Transversales , Femenino , Conocimientos, Actitudes y Práctica en Salud , Humanos , Jordania , Masculino , Tamaño de la Muestra , Autoinforme , Adulto Joven
14.
JAMA Netw Open ; 3(12): e2027082, 2020 12 01.
Artículo en Inglés | MEDLINE | ID: mdl-33306114

RESUMEN

Importance: Nimodipine is a highly prescribed drug for the treatment of cognitive impairment and dementia in Argentina. There is little evidence to support the use of nimodipine for cognitive impairment and dementia. Objective: To test the effectiveness of a behavioral intervention based on social norm feedback to reduce prescription of nimodipine for cognitive impairment in Argentina. Design, Setting, and Participants: This pragmatic parallel-group randomized clinical trial included 2 arms with a 1:1 allocation ratio. General practitioner physicians in the national health care system for older adults in Argentina (INSSJP-PAMI) with history of high nimodipine prescription rate were enrolled. The study was conducted from May 2019 to October 2019, and data were analyzed from November 2019 to February 2020. Interventions: The treatment group received 2 emails with evidence-based information about nimodipine plus the individual's level of nimodipine prescription compared with their peers. The control group received 2 emails with general information about the risks of overprescription in older adults. Main Outcomes and Measures: The primary outcome was the cumulative number of nimodipine prescriptions per 1000 prescriptions of all drugs made by the targeted physicians during the 6 months of the study. Secondary outcomes included annual monetary savings attributable to the intervention and physicians' qualitative perceptions of the acceptability of the procedure. Results: Of 1811 physicians enrolled, 906 physicians (354 [39.1%] women; mean [SD] age, 57.10 [10.73] years) were randomized to treatment and 905 participants (331 [36.6%] women; mean [SD] age, 56.49 [10.47] years) to the control group. Physicians in the treatment group wrote a mean of 93.25 (95% CI, 89.27 to 97.24) prescriptions of nimodipine, compared with 98.99 (95% CI, 95.00 to 102.98) prescriptions among practitioners in the control group during the half-year of the intervention (mean difference, -5.73 [95% CI, -11.38 to -0.10] prescriptions; P = .046), which meant a 5.79% reduction. Regression analysis revealed a significant association of the group condition with number of prescriptions per 1000 total prescriptions when controlling for baseline prescriptions (B = -0.312 [95% CI, -0.465 to -0.160]; P < .001). The observed difference corresponds to a 4.48% reduction in nimodipine prescriptions per 1000 prescriptions of all drugs made by physicians in the treated group compared with the control group. Physicians who effectively opened the email in the treatment group (427 physicians [47.1%]) prescribed the drug 11.3% less compared with the control group (426 physicians) (mean difference, -10.78 [95% CI, -18.53 to -3.03] prescriptions; P = .006). Expenditures were 7.18% lower in the treatment group, resulting in an estimated annual net cost benefit of US $234 893.35 (95% CI, $225 565.35 to $237 112.30). Conclusions and Relevance: In this randomized clinical trial, the social norm email feedback program showed an effect on curbing the nonrecommended prescription of nimodipine. It was highly cost-effective and well accepted by participants. Trial Registration: ISRCTN.org identifier: ISRCTN17823729.


Asunto(s)
Disfunción Cognitiva/tratamiento farmacológico , Abuso de Medicamentos/prevención & control , Abuso de Medicamentos/estadística & datos numéricos , Nimodipina/uso terapéutico , Pautas de la Práctica en Medicina/estadística & datos numéricos , Vasodilatadores/uso terapéutico , Adulto , Anciano , Atención Ambulatoria , Argentina , Prescripciones de Medicamentos/estadística & datos numéricos , Correo Electrónico , Femenino , Retroalimentación Formativa , Humanos , Masculino , Persona de Mediana Edad , Normas Sociales
15.
PLoS Negl Trop Dis ; 14(11): e0008862, 2020 11.
Artículo en Inglés | MEDLINE | ID: mdl-33206645

RESUMEN

The development of insecticide resistance is becoming a threat to many arboviruses control programs worldwide. While this has been attributed to the indiscriminate use of insecticide, a more theoretical study is apparently not available. Using in-silico experiments, we investigated the effects of two different policies: one used by the Brazilian Ministry of Health (which follows the World Health Organization protocol) and a more permissive one, akin to those employed by various gated communities and private companies. The results show that the public policy does not lead to resistance fixation. On the other hand, permissive application of adulticide, such as intensive domestic use mainly during epidemic periods, might lead to the fixation of a resistant population, even when resistance is associated with moderate fitness costs.


Asunto(s)
Aedes/efectos de los fármacos , Aedes/genética , Abuso de Medicamentos/estadística & datos numéricos , Resistencia a los Insecticidas/genética , Insecticidas/farmacología , Aedes/virología , Animales , Infecciones por Arbovirus/epidemiología , Infecciones por Arbovirus/transmisión , Brasil/epidemiología , Humanos , Modelos Teóricos , Control de Mosquitos/métodos , Mosquitos Vectores/efectos de los fármacos , Mosquitos Vectores/genética , Mosquitos Vectores/virología
16.
J Opioid Manag ; 16(5): 357-373, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33226093

RESUMEN

OBJECTIVE: The Centers for Disease Control and Prevention (CDC) recommend that clinicians prescribing opioids for chronic pain should consider at least annual urine drug testing (UDT). We evaluated whether shorter intervals for repeat UDT are associated with decreased rates of drug misuse. DESIGN: Retrospective analysis of deidentified serial UDT and matched prescribing data. SETTING: We analyzed Quest Diagnostics 2016-2017 UDT results from new patients being monitored for prescription drug adherence, in nonsubstance use disorder (SUD) treatment environments. MAIN OUTCOME MEASURES: Drug misuse was defined as the absence of a prescribed substance or the presence of a nonprescribed substance. Patients with ≥3 sets of the UDT results were included. RESULTS: UDT results from 49,601 patients (148,803 specimens) were tested. Declines in misuse between the first and second UDT were highest for those tested at the shortest intervals: approximately weekly, 19 percent; monthly, 15 percent; bimonthly, 12 percent; quarterly, 9 percent; semiannually, 3 percent; misuse rates increased by 1 percent for patients tested annually. Declines in misuse were more pronounced for opioids than other drug groups. Substantial declines in positivity were noted for heroin (32 percent) and nonprescribed fentanyl (10 percent). Declines in misuse between the second and third UDT followed a similar pattern. CONCLUSIONS: UDT intervals of ≤ quarterly were associated with marked declines, but testing annually or semiannually was not associated with consistent decreases. Our findings suggest that clinical strategies that include serial testing conducted quarterly or sooner may be instrumental in decreasing drug misuse. Testing more frequently than "at least once annually" should be considered by clinicians monitoring potential drug misuse.


Asunto(s)
Analgésicos Opioides/uso terapéutico , Dolor Crónico/tratamiento farmacológico , Abuso de Medicamentos/estadística & datos numéricos , Detección de Abuso de Sustancias/métodos , Adulto , Analgésicos Opioides/administración & dosificación , Abuso de Medicamentos/prevención & control , Femenino , Humanos , Masculino , Estudios Retrospectivos , Factores de Tiempo
17.
Ann Fam Med ; 18(6): 528-534, 2020 11.
Artículo en Inglés | MEDLINE | ID: mdl-33168681

RESUMEN

PURPOSE: We undertook a study to assess the associations between barriers to insurance coverage for gender-affirming hormones (either lack of insurance or claim denial) and patterns of hormone use among transgender adults. METHODS: We used data from the US Transgender Survey, a large national sample of 27,715 transgender adults, collected from August to September 2015. We calculated weighted proportions and performed multivariate logistic regression analyses. RESULTS: Of 12,037 transgender adults using hormones, 992 (9.17%) were using nonprescription hormones. Among insured respondents, 2,528 (20.81%) reported that their claims were denied. Use of nonprescription hormones was more common among respondents who were uninsured (odds ratio = 2.64; 95% CI, 1.88-3.71; P <.001) or whose claims were denied (odds ratio = 2.53; 95% CI, 1.61-3.97; P <.001). Uninsured respondents were also less likely to be using hormones (odds ratio = 0.37; 95% CI, 0.24-0.56; P <.001). CONCLUSIONS: Lack of insurance coverage for gender-affirming hormones is associated with lower overall odds of hormone use and higher odds of use of nonprescription hormones; such barriers may thus be linked to unmonitored and unsafe medication use, and increase the risks for adverse health outcomes. Ensuring access to hormones can decrease the economic burden transgender people face, and is an important part of harm-reduction strategies.


Asunto(s)
Terapia de Reemplazo de Hormonas/estadística & datos numéricos , Cobertura del Seguro/estadística & datos numéricos , Seguro de Salud/estadística & datos numéricos , Procedimientos de Reasignación de Sexo/estadística & datos numéricos , Personas Transgénero/estadística & datos numéricos , Adulto , Abuso de Medicamentos/estadística & datos numéricos , Femenino , Accesibilidad a los Servicios de Salud/estadística & datos numéricos , Encuestas Epidemiológicas , Hormonas/uso terapéutico , Humanos , Masculino , Pacientes no Asegurados/estadística & datos numéricos , Oportunidad Relativa , Estados Unidos
18.
PLoS One ; 15(9): e0238538, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32881969

RESUMEN

Self-medication and antibiotic utilization without healthcare oversight may lead to delayed appropriate treatment, transmission of communicable infections, untoward adverse events, and contribute to antimicrobial resistance. Previous data suggest people obtain over-the-counter (OTC) animal antibiotics for their personal use. This study examined the availability of OTC fish antibiotics online and the documented intent for self-medication. The authors conducted a web-based cross-sectional study using Google search engine to identify vendor websites selling fish antibiotics in the United States. Vendor websites were included if product information, consumer reviews, and comments were publicly available. Nine fish antibiotics were chosen due to their possibility of having consequences to human misuse. The cost and availability of fish antibiotics was recorded. The proportion of reviews and comments related to human consumption was calculated. Consumer review traffic based on "likes" and "dislikes" received was compared between human- and non-human consumption-related reviews. Selected fish antibiotics were purchased and evaluated for physical appearance and compared to FDA-approved available equivalents. We found 24 website vendors with online ordering available for OTC fish antibiotics. Cost varied significantly by antibiotic and quantity ranging from USD $8.99 to $119.99. There were 2,288 reviews documented for the 9 selected antibiotics being sold. Among consumer reviews, 2.4% were potentially associated with human consumption. Human consumption-related reviews constituted 30.2% of all "likes" received and 37.5% of all "dislikes" received. Human consumption-related reviews received an average of 9.2 likes compared to 0.52 likes for non-human consumption-related reviews. The 8 fish antibiotics purchased were consistent with FDA-approved equivalents in physical appearance. Although infrequent, antibiotics intended for fish use are being purchased online without a prescription for self-medication to circumvent professional medical care. Reviews related to human consumption generate significant online traffic compared to reviews unrelated to human consumption.


Asunto(s)
Antibacterianos/administración & dosificación , Abuso de Medicamentos/estadística & datos numéricos , Medicamentos sin Prescripción/administración & dosificación , Disponibilidad de Medicamentos Vía Internet/estadística & datos numéricos , Automedicación/estadística & datos numéricos , Drogas Veterinarias/administración & dosificación , Estudios Transversales , Humanos , Conocimiento de la Medicación por el Paciente , Motor de Búsqueda/estadística & datos numéricos , Estados Unidos
19.
PLoS One ; 15(9): e0239873, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32976542

RESUMEN

Widespread availability of antibiotics without prescription potentially facilitates overuse and contributes to selection pressure for antimicrobial resistant bacteria. Prior to this study, anecdotal observations in Guatemala identified corner stores as primary antibiotic dispensaries, where people purchase antibiotics without prescriptions. We carried out a cross sectional study to document the number and types of antibiotics available in corner stores, in four study areas in Guatemala. A total of 443 corner stores were surveyed, of which 295 (67%) sold antibiotics. The most commonly available antibiotics were amoxicillin, found in 246/295 (83%) stores, and tetracycline, found in 195/295 (66%) stores. Over the counter sales result from laissez-faire enforcement of antibiotic dispensing regulations in Guatemala combined with patient demand. This study serves as a baseline to document changes in the availability of antibiotics in informal establishments in light of new pharmacy regulations for antibiotic dispensing, which were adopted after this study was completed.


Asunto(s)
Antibacterianos/provisión & distribución , Utilización de Medicamentos/estadística & datos numéricos , Medicamentos sin Prescripción/provisión & distribución , Autoadministración/estadística & datos numéricos , Antibacterianos/administración & dosificación , Antibacterianos/economía , Abuso de Medicamentos/estadística & datos numéricos , Guatemala , Humanos , Medicamentos sin Prescripción/administración & dosificación , Medicamentos sin Prescripción/economía , Pequeña Empresa/estadística & datos numéricos
20.
An. pediatr. (2003. Ed. impr.) ; 93(3): 207.e1-207.e7, sept. 2020. tab
Artículo en Español | IBECS | ID: ibc-201559

RESUMEN

INTRODUCCIÓN: El uso racional de antibióticos (ATB) implica que los pacientes reciban ATB adecuados a sus necesidades clínicas, en dosis correctas según sus condiciones individuales, durante el tiempo adecuado y al menor costo para ellos y para su comunidad. La mayor tasa de abuso de ATB ocurre durante el período perinatal, a pesar de que existe evidencia de múltiples efectos negativos a corto y a largo plazo. Además, este abuso se asocia con incrementos en los costos de la atención médica. OBJETIVO: Actualizar y reportar la evidencia sobre el uso, abuso y efectos adversos de los ATB en medicina perinatal y las posibles medidas para prevenirlos y, de este modo, mejorar la calidad de los cuidados, los resultados y los costos. Métodos Revisión y análisis: de la literatura relacionada con el uso de ATB en perinatología hasta febrero de 2020. RESULTADOS: El abuso de ATB en perinatología oscila entre el 50 y el 70%, y aún más en algunas unidades neonatales. Los efectos adversos incluyen morbilidades agudas, muerte, aumento de resistencia microbiana, alteraciones del microbioma y disbiosis asociadas a complicaciones graves a lo largo de la vida, como infecciones, alergias, trastornos autoinmunes, enfermedades gastrointestinales, artritis, asma, obesidad y tal vez cáncer. Prevenir y disminuir el uso indebido de ATB conducirá a mejorar la salud y a ahorros significativos en el sector sanitario. En solamente 4unidades de cuidados intensivos neonatales (UCIN), con 1.000 admisiones anuales, el ahorro se estima en 230.000 dólares por año. CONCLUSIÓN: La necesidad de optimizar la utilización de ATB en la medicina perinatal nunca ha sido más urgente


INTRODUCTION: The rational use of antibiotics (ATB) implies that patients receive those adequate for their clinical needs, in correct doses according to their individual conditions, during an adequate period of time, and at the lowest cost for them and their community. The highest rate of ATB abuse occurs during the perinatal period, despite the fact that there is evidence of multiple short- and long-term negative effects. Furthermore, this abuse is associated with increased costs of medical care. OBJECTIVE: To update and report the evidence on the use, abuse, and adverse effects of ATB in perinatal medicine, and possible measures to prevent them, and thus improve health care outcomes and costs. METHODS: A review and analysis was performed from the literature related to the use of ATB in perinatal medicine up to February 2020. RESULTS: ATB abuse in perinatal medicine ranges from 50% to 70%, with even higher rates in some neonatal centres. Adverse effects include death, increased microbial resistance, along with microbiome abnormalities and dysbiosis that lead to serious life-long complications such as infections, allergies, autoimmune disorders, gastrointestinal disorders, arthritis, asthma, obesity, and perhaps cancer. Preventing and reducing the abuse of ATB would lead to better health and to significant savings in the health sector. In only 4neonatal intensive care units, with 1000 admissions per year, savings are estimated at US$230,000 per year. CONCLUSION: The need to optimise the use of ATB in perinatal medicine has never been more urgent


Asunto(s)
Humanos , Masculino , Femenino , Recién Nacido , Antibacterianos/uso terapéutico , Abuso de Medicamentos/estadística & datos numéricos , Atención Perinatal , Sepsis/tratamiento farmacológico , Antibacterianos/efectos adversos , Complicaciones Infecciosas del Embarazo/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...